149 related articles for article (PubMed ID: 2292349)
21. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
Johnston PS; Coniff RF; Hoogwerf BJ; Santiago JV; Pi-Sunyer FX; Krol A
Diabetes Care; 1994 Jan; 17(1):20-9. PubMed ID: 8112185
[TBL] [Abstract][Full Text] [Related]
22. Effect of miglitol and acarbose on starch digestion, daily plasma glucose profiles and cataract formation.
Madar Z; Hazan A
J Basic Clin Physiol Pharmacol; 1993; 4(1-2):69-81. PubMed ID: 8679512
[TBL] [Abstract][Full Text] [Related]
23. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
Johnson AB; Taylor R
Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
[TBL] [Abstract][Full Text] [Related]
24. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Russell JC; Graham SE; Dolphin PJ
Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
[TBL] [Abstract][Full Text] [Related]
25. Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose.
Lembcke B; Fölsch UR; Caspary WF; Ebert R; Creutzfeldt W
Digestion; 1982; 25(3):186-93. PubMed ID: 7160549
[TBL] [Abstract][Full Text] [Related]
26. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus.
Campbell LK; Baker DE; Campbell RK
Ann Pharmacother; 2000 Nov; 34(11):1291-301. PubMed ID: 11098345
[TBL] [Abstract][Full Text] [Related]
27. Miglitol, a new alpha-glucosidase inhibitor.
Sels JP; Huijberts MS; Wolffenbuttel BH
Expert Opin Pharmacother; 1999 Nov; 1(1):149-56. PubMed ID: 11249557
[TBL] [Abstract][Full Text] [Related]
28. The effects of the intestinal glucosidase inhibitory BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats.
DeBouno JF; Michaelis OE; Tulp OL
Gen Pharmacol; 1993 Mar; 24(2):509-15. PubMed ID: 8482529
[TBL] [Abstract][Full Text] [Related]
29. [Delayed absorption of carbohydrates in the therapy of Type II diabetes: comparison between dietary (Muesli) and pharmacological (Alpha-glucosidase inhibition) modification].
Willms B; Lübke D; Ahrens K; Arends J
Schweiz Med Wochenschr; 1991 Sep; 121(38):1379-82. PubMed ID: 1656521
[TBL] [Abstract][Full Text] [Related]
30. Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet.
Madar Z
Am J Clin Nutr; 1989 Jan; 49(1):106-11. PubMed ID: 2643291
[TBL] [Abstract][Full Text] [Related]
31. Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose.
Axen KV; Li X; Sclafani A
Obes Res; 1999 Jan; 7(1):83-9. PubMed ID: 10023734
[TBL] [Abstract][Full Text] [Related]
32. Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes.
Hillman RJ; Scott M; Gray RS
Diabetes Res; 1989 Feb; 10(2):81-4. PubMed ID: 2663321
[TBL] [Abstract][Full Text] [Related]
33. Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus.
Scott AR; Tattersall RB
Diabet Med; 1988 Jan; 5(1):42-6. PubMed ID: 2964327
[TBL] [Abstract][Full Text] [Related]
34. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
Fehmann HC
Fortschr Med Orig; 2001 Jul; 119 Suppl 2():55-61. PubMed ID: 15704357
[TBL] [Abstract][Full Text] [Related]
35. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
Reuser AJ; Wisselaar HA
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():19-24. PubMed ID: 8001622
[TBL] [Abstract][Full Text] [Related]
36. Effects of prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus.
Dimitriadis G; Hatziagelaki E; Ladas S; Linos A; Hillebrand I; Raptis S
Eur J Clin Invest; 1988 Feb; 18(1):33-8. PubMed ID: 3130257
[TBL] [Abstract][Full Text] [Related]
37. Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.
Pagano G; Marena S; Corgiat-Mansin L; Cravero F; Giorda C; Bozza M; Rossi CM
Diabete Metab; 1995 Jun; 21(3):162-7. PubMed ID: 7556806
[TBL] [Abstract][Full Text] [Related]
38. The effect of two new alpha-glucosidase inhibitors on metabolic responses to a mixed meal in normal volunteers.
Kennedy FP; Miles JM; Heiling V; Gerich JE
Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):633-40. PubMed ID: 3326689
[TBL] [Abstract][Full Text] [Related]
39. Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus.
Dimitriadis G; Hatziagellaki E; Alexopoulos E; Kordonouri O; Komesidou V; Ganotakis M; Raptis S
Diabetes Care; 1991 May; 14(5):393-8. PubMed ID: 2060451
[TBL] [Abstract][Full Text] [Related]
40. Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.
Dimitriadis G; Raptis S; Raptis A; Hatziagelaki E; Mitrakou A; Halvatsiotis P; Ladas S; Hillebrand I
Klin Wochenschr; 1986 May; 64(9):405-10. PubMed ID: 3520133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
